(Press-News.org) NEW ORLEANS, La. – Several Ochsner Health hospitals and partners across the Gulf South have earned an ‘A’ Leapfrog Hospital Safety Grade for Fall 2023.The Leapfrog Group, a national nonprofit watchdog that sets standards for excellence in patient care, assigns a grade to general hospitals across the country based on more than 30 national performance measures reflecting errors, accidents, injuries and infections, as well as the systems hospitals have in place to prevent them.
The following Ochsner Health hospitals and partners received an “A” grade from Leapfrog:
Leonard J. Chabert Medical Center
Ochsner Baptist – A Campus of Ochsner Medical Center
Ochsner Medical Center – Kenner
Ochsner Medical Center – New Orleans
Ochsner Medical Center– Hancock*
Ochsner Medical Center – Baton Rouge
Slidell Memorial Hospital East*
St. Bernard Parish Hospital*
St. Charles Parish Hospital*
*Received a “Straight A” for Fall 2023 Leapfrog Hospital Safety Grade for consistently demonstrating commitment to putting patients first year after year.
“Ochsner Health’s ‘A’ grades are a direct result of our teams continually putting patients first throughout every aspect of care. Their hard work and dedication to provide high quality care for our community is unmatched,” said Robert Hart, MD, chief physician executive, Ochsner Health. “I am proud of the environment we have created for our patients.”
“Earning an ‘A’ Grade means Ochsner Health hospitals and partners made a true commitment to put patients first,” said Leah Binder, president and CEO of The Leapfrog Group. “We congratulate the leadership, Board, clinicians, staff and volunteers that all had a role to play in this achievement.”
To see Ochsner Health’s full grade details and to access patient tips for staying safe in the hospital, visit www.hospitalsafetygrade.org and follow The Leapfrog Group on Twitter, Facebook and via its newsletter. To learn more about Ochsner Health, please visit www.ochsner.org.
###
About Ochsner Health
Ochsner Health is an integrated healthcare system with a mission to Serve, Heal, Lead, Educate and Innovate. Celebrating more than 80 years of service, it leads nationally in cancer care, cardiology, neurosciences, liver and kidney transplants and pediatrics, among other areas. Ochsner is consistently named both the top hospital and top children’s hospital in Louisiana by U.S. News & World Report. The not-for-profit organization is inspiring healthier lives and stronger communities through its Healthy State initiative, a bold and collaborative plan to realize a healthier Louisiana. Its focus is on preventing diseases and providing patient-centered care that is accessible, affordable, convenient and effective. Ochsner Health pioneers new treatments, deploys emerging technologies and performs groundbreaking research, including 4,000 patients enrolled in 685 clinical studies in 2022. It has more than 37,000 employees and over 4,700 employed and affiliated physicians in over 90 medical specialties and subspecialties. It operates 46 hospitals and more than 370 health and urgent care centers across Louisiana, Mississippi, Alabama and the Gulf South; and its cutting-edge Connected Health digital medicine program is caring for patients beyond its walls. In 2022, Ochsner Health treated more than 1.4 million people from every state and 62 countries. As Louisiana’s top healthcare educator of physicians, Ochsner Health and its partners educate thousands of healthcare professionals annually. To learn more, visit https://www.ochsner.org/.
About The Leapfrog Group
About The Leapfrog Group Founded in 2000 by large employers and other purchasers, The Leapfrog Group is a national nonprofit organization driving a movement for giant leaps for patient safety. The flagship Leapfrog Hospital Survey and Leapfrog Ambulatory Surgery Center (ASC) Survey collect and transparently report hospital and ASC performance, empowering purchasers to find the highest-value care and giving consumers the lifesaving information they need to make informed decisions. The Leapfrog Hospital Safety Grade, Leapfrog's other main initiative, assigns letter grades to hospitals based on their record of patient safety, helping consumers protect themselves and their families from errors, injuries, accidents and infections. For more, follow us on Twitter and Facebook, and sign up for our newsletter.
END
Technology is edging closer and closer to the super-speed world of computing with artificial intelligence. But is the world equipped with the proper hardware to be able to handle the workload of new AI technological breakthroughs?
“The brain-inspired codes of the AI revolution are largely being run on conventional silicon computer architectures which were not designed for it,” explains Erica Carlson, 150th Anniversary Professor of Physics and Astronomy at Purdue University.
A joint effort between Physicists from Purdue University, University of California San Diego (USCD) and École ...
Researchers at the Beckman Institute for Advanced Science and Technology developed an automated laboratory robot to run complex electrochemical experiments and analyze data.
With affordability and accessibility in mind, the researchers collaboratively created a benchtop robot that rapidly performs electrochemistry. Aptly named the Electrolab, this instrument greatly reduces the effort and time needed for electrochemical studies by automating many basic and repetitive laboratory tasks.
The Electrolab can be used to explore energy storage materials and chemical reactions that promote the use of alternative ...
The fight against dengue fever has a new weapon: a mosquito infected with the bacteria Wolbachia, which prevents the spread of the virus. These mosquitoes have now been deployed in several trials demonstrating their potential in preventing disease transmission.
Now, researchers at the University of Notre Dame have conducted an analysis of the World Mosquito Program’s randomized control trial of Wolbachia-infected mosquitoes in Indonesia, looking at how excluding transmission dynamics impacted the original interpretation of the trial’s results.
“Randomized controlled trials are the gold standard for evaluating the efficacy of any ...
“Our research study has demonstrated that poziotinib is highly potent in neratinib-resistant HER2 L755S lobular and ductal breast cancer models [...].”
BUFFALO, NY- November 6, 2023 – A new editorial paper was published in Oncotarget's Volume 14 on October 31, 2023, entitled, “The uncharted role of HER2 mutant alleles in breast cancer.”
Somatic HER2 mutations are a novel class of therapeutic targets across different cancer types. Treatment with the tyrosine kinase inhibitor (TKI) neratinib ...
WASHINGTON – Warren Wood, Ph.D., U.S. Naval Research Laboratory Ocean Sciences Division’s Geology and Geophysics section head, received the National Defense Industrial Association (NDIA) Bronze Medal on Sept. 19, 2023 during a ceremony held at the Naval Submarine Base in Groton, Conn. for outstanding individual achievement in undersea warfare.
This award-winning work would not have been possible without fantastic teamwork, especially from the staff in Geology and Geophysics and Acoustic Simulation, Measurements & Tactics Branches,” said Wood. “Essentially a software ...
A new study, "Timing of Orthostatic Hypotension and its Relationship with Falls in Older Adults", has brought critical insights into the assessment of orthostatic hypotension, a drop in blood pressure commonly found among older adults when transitioning from a sitting or lying position to a standing position that can lead to dizziness and falls.
Published in the Journal of the American Geriatrics Society (JAGS) and based on a secondary analysis of the "Study to Understand Fall Reduction and Vitamin D in You (STURDY)," this study examined the prevalence of orthostatic hypotension at different time points after ...
As parasites adapt to a warming world, an infectious disease expert at Rochester Institute of Technology has his eye on the tsetse fly in sub-Saharan Africa. The biting fly transmits Trypanosomiasis, or “sleeping sickness,” to cattle there and could someday migrate to northern climates, including to the United States.
RIT researcher Bolaji Thomas is leading a $650,000 study funded by the U.S. Department of Agriculture, the National Institute of Food and Agriculture, and the Agriculture ...
CAR-T cell therapy is a last hope for many patients with blood, bone marrow or lymph gland cancer when other treatments such as chemotherapy are unsuccessful. A limiting factor of this otherwise very effective and safe therapy is that the cells used in the process quickly reach a state of exhaustion. Researchers at the University of Freiburg have now been able to prevent this exhaustion and thus significantly improve the effect of the therapy in a preclinical animal model. The new results have been published in the journal Nature Immunology.
Using the body’s own defences ...
A team of University of Maryland researchers developed a nasal spray vaccine that delivers the SARS-CoV-2 spike protein into cells of the airway in mice and hamsters, triggering an immune response that significantly reduced infection and spread of COVID-19. The technology can be adapted to induce immunity to other respiratory illnesses, such as influenza and respiratory syncytial virus (RSV) infections.
A nasal vaccine for respiratory viruses would be a significant improvement over intramuscular shots, because they are less invasive and stop viral particle replication in the airway, before a virus can enter the bloodstream. This could improve the rate ...
Simon Fraser University researchers studying the evolutionary history of flu viruses have found that a new quantitative analysis of how they evolved may help predict future strains. The research draws on a field known as phylogenetics, which focuses on how groups of organisms are evolutionarily related, and is published in the journal Science Advances.
Researchers used large phylogenetic ‘trees’ to predict which strains are most likely to grow during the upcoming flu season, and determined that this approach was moderately effective in detecting future strains of the influenza virus, and could be another tool in the toolbox to guide seasonal ...
